Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Disentangling psychopathology, substance use and dependence: a factor analysis.

Delgadillo J, Böhnke JR, Hughes E, Gilbody S.

BMC Psychiatry. 2016 Aug 8;16:281. doi: 10.1186/s12888-016-0988-1.

2.

Elevated baseline serum glutamate as a pharmacometabolomic biomarker for acamprosate treatment outcome in alcohol-dependent subjects.

Nam HW, Karpyak VM, Hinton DJ, Geske JR, Ho AM, Prieto ML, Biernacka JM, Frye MA, Weinshilboum RM, Choi DS.

Transl Psychiatry. 2015 Aug 18;5:e621. doi: 10.1038/tp.2015.120.

3.

Prescription opioid misuse and mental health among young injection drug users.

Mackesy-Amiti ME, Donenberg GR, Ouellet LJ.

Am J Drug Alcohol Abuse. 2015 Jan;41(1):100-6. doi: 10.3109/00952990.2014.940424. Epub 2014 Aug 8.

4.

Racial/ethnic match and treatment outcomes for women with PTSD and substance use disorders receiving community-based treatment.

Ruglass LM, Hien DA, Hu MC, Campbell AN, Caldeira NA, Miele GM, Chang DF.

Community Ment Health J. 2014 Oct;50(7):811-22. doi: 10.1007/s10597-014-9732-9. Epub 2014 May 10.

5.

Attendance and substance use outcomes for the Seeking Safety program: sometimes less is more.

Hien DA, Morgan-Lopez AA, Campbell AN, Saavedra LM, Wu E, Cohen L, Ruglass L, Nunes EV.

J Consult Clin Psychol. 2012 Feb;80(1):29-42. doi: 10.1037/a0026361. Epub 2011 Dec 19.

6.

Stressful life events and suicidal behavior in adults with alcohol use disorders: role of event severity, timing, and type.

Conner KR, Houston RJ, Swogger MT, Conwell Y, You S, He H, Gamble SA, Watts A, Duberstein PR.

Drug Alcohol Depend. 2012 Jan 1;120(1-3):155-61. doi: 10.1016/j.drugalcdep.2011.07.013. Epub 2011 Aug 10.

7.

Comorbid mental disorders in substance users from a single catchment area--a clinical study.

Langås AM, Malt UF, Opjordsmoen S.

BMC Psychiatry. 2011 Feb 12;11:25. doi: 10.1186/1471-244X-11-25.

8.

Antidepressant treatment does not improve buprenorphine retention among opioid-dependent persons.

Stein MD, Herman DS, Kettavong M, Cioe PA, Friedmann PD, Tellioglu T, Anderson BJ.

J Subst Abuse Treat. 2010 Sep;39(2):157-66. doi: 10.1016/j.jsat.2010.05.014. Epub 2010 Jul 3.

9.

Neurocognition in individuals co-infected with HIV and hepatitis C.

Hinkin CH, Castellon SA, Levine AJ, Barclay TR, Singer EJ.

J Addict Dis. 2008;27(2):11-7. doi: 10.1300/J069v27n02_02.

10.

An exploratory study of long-term neurocognitive outcomes following recovery from opportunistic brain infections in HIV+ adults.

Levine AJ, Hinkin CH, Ando K, Santangelo G, Martinez M, Valdes-Sueiras M, Saxton EH, Mathisen G, Commins DL, Moe A, Farthing C, Singer EJ.

J Clin Exp Neuropsychol. 2008 Oct;30(7):836-43. doi: 10.1080/13803390701819036. Epub 2008 Feb 8.

11.

Meta-analysis of depression and substance use and impairment among cocaine users.

Conner KR, Pinquart M, Holbrook AP.

Drug Alcohol Depend. 2008 Nov 1;98(1-2):13-23. doi: 10.1016/j.drugalcdep.2008.05.005. Epub 2008 Jun 27.

12.

Assessing addiction: concepts and instruments.

Samet S, Waxman R, Hatzenbuehler M, Hasin DS.

Addict Sci Clin Pract. 2007 Dec;4(1):19-31. Review.

13.

Co-occurring disorders in substance abuse treatment: issues and prospects.

Flynn PM, Brown BS.

J Subst Abuse Treat. 2008 Jan;34(1):36-47. Epub 2007 Jun 15. Review.

14.

Using addiction severity profiles to differentiate cocaine-dependent patients with and without comorbid major depression.

Leventhal AM, Mooney ME, DeLaune KA, Schmitz JM.

Am J Addict. 2006 Sep-Oct;15(5):362-9.

Supplemental Content

Support Center